AU2001276395A1 - Direct assessment of relative concentrations of variants of an epitope on a dimeric molecule - Google Patents

Direct assessment of relative concentrations of variants of an epitope on a dimeric molecule

Info

Publication number
AU2001276395A1
AU2001276395A1 AU2001276395A AU7639501A AU2001276395A1 AU 2001276395 A1 AU2001276395 A1 AU 2001276395A1 AU 2001276395 A AU2001276395 A AU 2001276395A AU 7639501 A AU7639501 A AU 7639501A AU 2001276395 A1 AU2001276395 A1 AU 2001276395A1
Authority
AU
Australia
Prior art keywords
epitope
variants
relative concentrations
direct assessment
dimeric molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276395A
Inventor
Werner Naser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001276395A1 publication Critical patent/AU2001276395A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001276395A 2000-07-12 2001-07-11 Direct assessment of relative concentrations of variants of an epitope on a dimeric molecule Abandoned AU2001276395A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00115163 2000-07-12
EP00115163 2000-07-12
PCT/EP2001/007985 WO2002008722A2 (en) 2000-07-12 2001-07-11 Direct assessment of relative concentrations of variants of an epitope on a dimeric molecule

Publications (1)

Publication Number Publication Date
AU2001276395A1 true AU2001276395A1 (en) 2002-02-05

Family

ID=8169239

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276395A Abandoned AU2001276395A1 (en) 2000-07-12 2001-07-11 Direct assessment of relative concentrations of variants of an epitope on a dimeric molecule

Country Status (2)

Country Link
AU (1) AU2001276395A1 (en)
WO (1) WO2002008722A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4402756A1 (en) * 1994-01-31 1995-08-03 Boehringer Mannheim Gmbh Specific binding substances for antibodies and their use for immunoassays or vaccines
AU6764196A (en) * 1995-08-31 1997-03-19 First Medical, Inc. Methods and antibodies for detecting creatine kinase
DE69705423T2 (en) * 1996-12-09 2002-05-16 Osteometer Biotech As Herlev SANDWEIGHT TEST FOR DETECTING COLLAGEN FRAGMENTS
CA2290582C (en) * 1997-05-14 2005-08-02 Kenneth F. Buechler Rapid evaluation of the ratio of biological molecules

Also Published As

Publication number Publication date
WO2002008722A2 (en) 2002-01-31
WO2002008722A3 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
AU2001269503A1 (en) Amino alcohol derivatives
AU7348000A (en) Voice recognition for internet navigation
AU7991400A (en) Technique for effective navigation based on user preferences
AU2001280187A1 (en) Cyclic amine derivatives
AU2002214471A1 (en) Map-aided positioning
AU2001263873A1 (en) Cosmetic agents containing 2-furanone derivatives
AU2001278093A1 (en) Integrated sensor
AUPR105000A0 (en) Method for generating and detecting marks
AUPR034000A0 (en) Aminoalcohol derivatives
AU2001233093A1 (en) Gas sensor
AU2002303164A1 (en) Fatty amine drug conjugates
AUPQ585000A0 (en) Aminoalcohol derivatives
AU2002316656A1 (en) Database navigation
AU3942901A (en) Navigational aid
AU2001264974A1 (en) Method for generating an insurance quote
AU4430701A (en) Compounds for targeting
AU2001224818A1 (en) Device for administering liquids
AU2001252418A1 (en) Nasal packing device
AU2001245867A1 (en) Creatine containing caramel
AU2001276395A1 (en) Direct assessment of relative concentrations of variants of an epitope on a dimeric molecule
AU2001284545A1 (en) Navigator
GB2360518B (en) Dimeric compounds
AU2001269839A1 (en) Car locator
AU2001294474A1 (en) Navigation device
AU2001287933A1 (en) Amine compounds